227 related articles for article (PubMed ID: 30747408)
1. Clinicopathological Significance of Overall Frequency of Allelic Loss (OFAL) in Lesions Derived from Thyroid Follicular Cell.
Migdalska-Sęk M; Czarnecka KH; Kusiński M; Pastuszak-Lewandoska D; Nawrot E; Kuzdak K; Brzeziańska-Lasota E
Mol Diagn Ther; 2019 Jun; 23(3):369-382. PubMed ID: 30747408
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the frequency of genetic alterations (LOH/MSI) in patients with intraepithelial cervical lesions with HPV infection: a pilot study.
Migdalska-Sęk M; Karowicz-Bilińska A; Pastuszak-Lewandoska D; Czarnecka KH; Nawrot E; Domańska-Senderowska D; Kiszałkiewicz J; Brzeziańska-Lasota E
Med Oncol; 2016 May; 33(5):51. PubMed ID: 27090798
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of DNA alteration: loss of heterozygosity or allelic imbalance-promising for molecular staging of prostate cancers.
Bryś M; Migdalska-Sęk M; Pastuszak-Lewandoska D; Forma E; Czarnecka K; Domańska D; Nawrot E; Wilkosz J; Różański W; Brzeziańska E
Med Oncol; 2013 Mar; 30(1):391. PubMed ID: 23288724
[TBL] [Abstract][Full Text] [Related]
4. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
Singh RB; Amare Kadam PS
Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
[TBL] [Abstract][Full Text] [Related]
5. Allelic imbalance in 1p, 7q, 9p, 11p, 12q and 16q regions in non-small cell lung carcinoma and its clinical association: a pilot study.
Czarnecka KH; Migdalska-Sęk M; Antczak A; Pastuszak-Lewandoska D; Kordiak J; Nawrot E; Domańska D; Kaleta D; Górski P; Brzeziańska EB
Mol Biol Rep; 2013 Dec; 40(12):6671-84. PubMed ID: 24091944
[TBL] [Abstract][Full Text] [Related]
6. Differential loss of heterozygosity at 7q31.2 in follicular and papillary thyroid tumors.
Zhang JS; Nelson M; McIver B; Hay ID; Goellner JR; Grant CS; Eberhardt NL; Smith DI
Oncogene; 1998 Aug; 17(6):789-93. PubMed ID: 9715281
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity of the long arm of chromosome 7 in follicular and anaplastic thyroid cancer, but not in papillary thyroid cancer.
Trovato M; Fraggetta F; Villari D; Batolo D; Mackey K; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 1999 Sep; 84(9):3235-40. PubMed ID: 10487693
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity in follicular and papillary thyroid carcinomas.
Rodrigues-Serpa A; Catarino A; Soares J
Cancer Genet Cytogenet; 2003 Feb; 141(1):26-31. PubMed ID: 12581895
[TBL] [Abstract][Full Text] [Related]
9. MSI and LOH in the development and prognosis of follicular cell-derived thyroid tumours.
Migdalska-Sęk M; Pastuszak-Lewandoska D; Brzeziańska E
Endokrynol Pol; 2012; 63(2):126-36. PubMed ID: 22538752
[TBL] [Abstract][Full Text] [Related]
10. High resolution loss of heterozygosity mapping of 17p13 in thyroid cancer: Hurthle cell carcinomas exhibit a small 411-kilobase common region of allelic imbalance, probably containing a novel tumor suppressor gene.
Farrand K; Delahunt B; Wang XL; McIver B; Hay ID; Goellner JR; Eberhardt NL; Grebe SK
J Clin Endocrinol Metab; 2002 Oct; 87(10):4715-21. PubMed ID: 12364463
[TBL] [Abstract][Full Text] [Related]
11. Frequent loss of heterozygosity on chromosomes 3p and 17p without VHL or p53 mutations suggests involvement of unidentified tumor suppressor genes in follicular thyroid carcinoma.
Grebe SK; McIver B; Hay ID; Wu PS; Maciel LM; Drabkin HA; Goellner JR; Grant CS; Jenkins RB; Eberhardt NL
J Clin Endocrinol Metab; 1997 Nov; 82(11):3684-91. PubMed ID: 9360526
[TBL] [Abstract][Full Text] [Related]
12. Cytogenetic and molecular genetic studies of follicular and papillary thyroid cancers.
Herrmann MA; Hay ID; Bartelt DH; Ritland SR; Dahl RJ; Grant CS; Jenkins RB
J Clin Invest; 1991 Nov; 88(5):1596-604. PubMed ID: 1939648
[TBL] [Abstract][Full Text] [Related]
13. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
14. Investigation of allelic imbalances on chromosome 3p in nasopharyngeal carcinoma in Tunisia: high frequency of microsatellite instability in patients with early-onset of the disease.
Trimeche M; Braham H; Ziadi S; Amara K; Hachana M; Korbi S
Oral Oncol; 2008 Aug; 44(8):775-83. PubMed ID: 18206419
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity: an independent prognostic factor of colorectal cancer.
Chang SC; Lin JK; Lin TC; Liang WY
World J Gastroenterol; 2005 Feb; 11(6):778-84. PubMed ID: 15682467
[TBL] [Abstract][Full Text] [Related]
16. Microsatellite Instability Occurs in a Subset of Follicular Thyroid Cancers.
Genutis LK; Tomsic J; Bundschuh RA; Brock PL; Williams MD; Roychowdhury S; Reeser JW; Frankel WL; Alsomali M; Routbort MJ; Broaddus RR; Wakely PE; Phay JE; Walker CJ; de la Chapelle A
Thyroid; 2019 Apr; 29(4):523-529. PubMed ID: 30747051
[TBL] [Abstract][Full Text] [Related]
17. Loss of heterozygosity and its correlation with clinical outcome and Epstein-Barr virus infection in nasopharyngeal carcinoma.
Shao JY; Huang XM; Yu XJ; Huang LX; Wu QL; Xia JC; Wang HY; Feng QS; Ren ZF; Ernberg I; Hu LF; Zeng YX
Anticancer Res; 2001; 21(4B):3021-9. PubMed ID: 11712805
[TBL] [Abstract][Full Text] [Related]
18. Functional loss of tumor suppressor genes detected by loss of heterozygosity, but not driver mutations, predicts aggressive lymph node status in papillary thyroid carcinoma.
Finkelstein S; Timmaraju VA; Samankan S; O'Malley Q; Kapustin D; Spaulding S; Xing M; Matloob A; Beute J; Seo G; Saturno M; Greenberg L; Wein L; Gonzalez-Velazquez C; Doyle S; Levine J; Urken M; Brandwein-Weber M
Pathol Res Pract; 2023 Nov; 251():154842. PubMed ID: 37890270
[TBL] [Abstract][Full Text] [Related]
19. Clinico-pathological significance of cell-type-specific loss of heterozygosity on chromosome 7q21: analysis of 318 microdissected thyroid lesions.
Trovato M; Ulivieri A; Dominici R; Ruggeri RM; Vitarelli E; Benvenga S; Barresi G; Trimarchi F; Brunetti E; Vecchione A; Andreoli M; Sciacchitano S
Endocr Relat Cancer; 2004 Jun; 11(2):365-76. PubMed ID: 15163311
[TBL] [Abstract][Full Text] [Related]
20. Somatic mutation and germline variants of MINPP1, a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular thyroid carcinomas.
Gimm O; Chi H; Dahia PL; Perren A; Hinze R; Komminoth P; Dralle H; Reynolds PR; Eng C
J Clin Endocrinol Metab; 2001 Apr; 86(4):1801-5. PubMed ID: 11297621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
